Workflow
Shareholder rights litigation
icon
Search documents
OLO Investors Have the Opportunity to Join Investigation of Olo Inc. with the Schall Law Firm
Prnewswire· 2025-08-21 08:45
Core Viewpoint - The Schall Law Firm is investigating potential breaches of fiduciary duty by the directors and management of Olo Inc. in relation to its acquisition by Thoma Bravo for $10.25 per share [1]. Group 1 - The investigation by the Schall Law Firm focuses on whether the Olo board acted in the best interests of its shareholders during the acquisition process [1]. - Olo Inc. has agreed to be acquired by Thoma Bravo at a price of $10.25 per share [1].
Biohaven Ltd. Stockholders are Urged to Seek Representation to Lead the BHVN Class Action: Contact Robbins LLP for More Information
Prnewswire· 2025-08-20 21:38
Core Viewpoint - A class action has been filed against Biohaven Ltd. for allegedly misleading investors regarding the viability of its drug candidates, particularly troriluzole and BHV-7000, during the period from March 24, 2023, to May 14, 2025 [1][2]. Group 1: Company Overview - Biohaven Ltd. is a biopharmaceutical company focused on developing therapies in immunology, neuroscience, and oncology [1]. - The company is working on several product candidates, including troriluzole for spinocerebellar ataxia (SCA) and BHV-7000 for bipolar disorder [1]. Group 2: Allegations and Legal Action - The class action alleges that Biohaven overstated the regulatory prospects and data sufficiency for troriluzole's approval for SCA [2]. - It is also claimed that the efficacy and clinical prospects of BHV-7000 for bipolar disorder were similarly overstated [2]. - The complaint suggests that the eventual revelation of these issues could significantly negatively impact Biohaven's business and financial condition [2]. Group 3: Class Action Participation - Shareholders interested in serving as lead plaintiffs must file their papers by September 12, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3].
Flywire Corporation Stock News: FLYW Investors with Large Losses Should Contact Robbins LLP for Information About Leading the FLYW Class Action Lawsuit
Prnewswire· 2025-08-20 21:30
Core Points - A class action has been filed against Flywire Corporation on behalf of investors who acquired its securities between February 28, 2024, and February 25, 2025 [1] - Allegations include that Flywire misled investors about the sustainability of its revenue growth and downplayed the negative impact of permit and visa-related restrictions on its business [2] - On February 25, 2025, Flywire announced disappointing financial results for Q4 and FY 2024, expecting revenue declines of over 30% year-over-year in Canadian and Australian markets due to policy changes and new visa rules [3] - Following the announcement, Flywire's stock price dropped by $6.59, or 37.36%, closing at $11.05 per share on February 26, 2025 [3] Company and Industry Summary - Flywire operates as a payments-enablement and software company both in the U.S. and internationally [1] - The company is facing scrutiny regarding its revenue growth claims and the effects of regulatory changes on its operations [2] - The recent financial disclosures have led to analyst downgrades and price target cuts, indicating a negative outlook for the company's performance [3]
Sable Offshore Corp. Stock News: SOC Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Class Action Lawsuit Against SOC
Prnewswire· 2025-08-20 21:30
Group 1 - A class action has been filed on behalf of investors who purchased Sable Offshore Corp. (NYSE: SOC) securities between May 19, 2025, and June 3, 2025, and/or traceable to the Company's May 21, 2025 secondary public offering [1] - The allegations state that Sable Offshore Corp. misled investors by claiming that oil production had restarted off the coast of California when it had not, leading to investor losses when the truth was revealed [2] - Shareholders interested in serving as lead plaintiff must submit their papers by September 26, 2025, and can remain absent class members if they choose not to participate [3] Group 2 - Robbins LLP operates on a contingency fee basis, meaning shareholders pay no fees or expenses for representation [4] - Robbins LLP has been dedicated to helping shareholders recover losses and improve corporate governance since 2002 [4]
Investor Alert: Robbins LLP Informs Investors of the Charter Communications, Inc. Class Action
Prnewswire· 2025-08-18 06:05
Core Viewpoint - A class action lawsuit has been filed against Charter Communications, Inc. for allegedly misleading investors about its business prospects, particularly regarding the impact of the Affordable Connectivity Program's end on customer declines and revenue [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Charter failed to disclose the material impact of the Affordable Connectivity Program (ACP) ending, which affected Internet customer declines and revenue [2]. - It is alleged that Charter's operational strategies were not sufficient to mitigate the negative effects of the ACP ending, leading to greater risks to business plans and earnings growth than reported [2]. - The company reportedly provided overly optimistic statements about its operational execution and long-term EBITDA growth without a reasonable basis [2]. Group 2: Financial Performance - Charter reported an EBITDA of $5.7 billion for Q2 2025, indicating a year-over-year growth of 0.5%. However, this growth was attributed to a one-time benefit of $45 million in "other revenue" [3]. - Excluding this one-time benefit, EBITDA would have missed consensus estimates by 2.4% and shown a decline of 0.3% year-over-year [3]. - Following the financial results announcement, Charter's stock price dropped by $70.25, or over 18%, closing at $309.75 per share on July 25, 2025 [3].
Investor Alert: Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Class Action
Prnewswire· 2025-08-18 06:03
Core Viewpoint - A class action has been filed against Unicycive Therapeutics, Inc. for allegedly misleading investors regarding the readiness of its drug application and compliance with FDA manufacturing requirements [1][2]. Group 1: Allegations and Legal Action - Robbins LLP is investigating allegations that Unicycive Therapeutics misled investors about the prospects of its New Drug Application (NDA) for oxylanthanum carbonate (OLC) [2]. - The complaint claims that Unicycive overstated its readiness to meet FDA manufacturing compliance requirements [2]. - Shareholders are encouraged to participate in the class action and can contact Robbins LLP before the October 14, 2025 deadline to serve as lead plaintiff [4]. Group 2: Stock Performance and FDA Actions - On June 10, 2025, Unicycive announced that the FDA identified deficiencies in cGMP compliance at a third-party manufacturing vendor, leading to a stock price drop of over 40% [3]. - Following the FDA's issuance of a Complete Response Letter for the OLC NDA on June 30, 2025, Unicycive's stock fell nearly 30%, closing at $4.77 per share [3].
FI Stock News: Investors with Large Losses Should Contact Robbins LLP to Learn About Leading the Fiserv, Inc. Class Action Lawsuit
Prnewswire· 2025-08-12 23:56
Core Viewpoint - Robbins LLP has filed a class action on behalf of investors who acquired Fiserv, Inc. common stock during a specified period, alleging that the company misled investors regarding the growth prospects of its Clover platform [1][2]. Allegations - Fiserv allegedly forced Payeezy merchants to migrate to its Clover platform due to cost issues and problems with Payeezy, which temporarily boosted Clover's revenue and GPV growth, concealing a slowdown in new merchant business [2]. - Following the forced conversions, many former Payeezy merchants switched to competing solutions due to Clover's high pricing and inadequate customer service, leading to a significant slowdown in Clover's GPV growth and unsustainable revenue growth [2]. - The positive statements made by Fiserv regarding Clover's growth strategies and business prospects during the class period were claimed to be materially false and misleading [2]. Impact on Stock - The truth regarding these issues was revealed through a series of disclosures, resulting in a decline in Fiserv, Inc.'s stock and harming investors [3]. Next Steps for Shareholders - Shareholders interested in serving as lead plaintiffs must file their motions by September 22, 2025, while those who choose not to participate can remain as absent class members [4]. Company Background - Robbins LLP has been dedicated to helping shareholders recover losses and improve corporate governance since 2002, operating on a contingency fee basis where shareholders pay no fees or expenses [5].
CNC Stock News: Investors with Large Losses Should Contact Robbins LLP to Learn About Leading the Centene Corporation Class Action Lawsuit
Prnewswire· 2025-08-12 23:56
Group 1 - A class action has been filed against Centene Corporation on behalf of investors who acquired its securities between December 12, 2024, and June 30, 2025 [1] - Allegations state that Centene misled investors about its business prospects, creating a false impression of reliable revenue outlook and growth while actual enrollment rates and morbidity were lower than expected [2] - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that market growth across 22 states was lower than anticipated, leading to a reduction in guidance to approximately $1.8 billion and an adjusted diluted EPS of $2.75 [3] Group 2 - Following the announcement on July 1, 2025, Centene's stock price dropped from $56.65 to $44.78 per share, a decline of over 40% [3] - Shareholders are encouraged to participate in the class action, with options to serve as lead plaintiff or remain an absent class member [4] - Robbins LLP has been dedicated to shareholder rights litigation since 2002, focusing on helping shareholders recover losses and improve corporate governance [5]
Sable Offshore Corp. Stockholders with Large Losses Should Contact Robbins LLP for Information About the SOC Class Action Lawsuit
Prnewswire· 2025-08-12 22:46
Group 1 - A class action has been filed on behalf of investors who purchased Sable Offshore Corp. (NYSE: SOC) securities between May 19, 2025, and June 3, 2025, related to the company's secondary public offering on May 21, 2025 [1][2] - The allegations state that Sable Offshore Corp. misled investors by claiming that oil production had restarted off the coast of California when it had not, leading to investor losses when the truth was revealed [2] - Shareholders interested in serving as lead plaintiff must submit their papers by September 26, 2025, and can choose to remain absent class members if they do not wish to participate [3] Group 2 - Robbins LLP is a recognized leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [4]
Lockheed Martin Corporation Stockholders with Large Losses are Encouraged to Contact Robbins LLP Regarding the LMT Class Action Lawsuit
Prnewswire· 2025-08-12 22:44
SAN DIEGO, Aug. 12, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025. Lockheed Martin is an aerospace defense company. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Lockheed Martin Corporation (LMT) M ...